1. Academic Validation
  2. A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli

A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli

  • J Med Chem. 2020 Jun 11;63(11):5990-6002. doi: 10.1021/acs.jmedchem.0c00255.
Joel A Goldberg 1 Ha Nguyen 2 Vijay Kumar 2 Elizabeth J Spencer 3 Denton Hoyer 3 Emma K Marshall 1 Anna Cmolik 1 Margaret O'Shea 1 Steven H Marshall 1 Andrea M Hujer 1 4 Kristine M Hujer 1 4 Susan D Rudin 1 4 T Nicholas Domitrovic 1 4 Christopher R Bethel 1 Krisztina M Papp-Wallace 1 2 4 Latania K Logan 5 6 Federico Perez 1 4 7 Michael R Jacobs 4 8 David van Duin 9 Barry M Kreiswirth 10 Robert A Bonomo 1 2 4 7 11 12 Mark S Plummer 3 Focco van den Akker 2
Affiliations

Affiliations

  • 1 Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
  • 2 Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106, United States.
  • 3 Yale Center for Molecular Discovery, West Haven, Connecticut 06516, United States.
  • 4 Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, United States.
  • 5 Department of Pediatrics, Rush University Medical Center, Rush Medical College, Chicago, Illinois 60612, United States.
  • 6 Cook County Health and Hospital Systems, Chicago, Illinois 60612, United States.
  • 7 Geriatric Research, Education and Clinical Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
  • 8 Department of Pathology, University Hospitals Cleveland Medical Center, Division of Clinical Microbiology, Cleveland, Ohio 44106, United States.
  • 9 University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514, United States.
  • 10 Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey 07601, United States.
  • 11 Departments of Pharmacology, Molecular Biology & Microbiology, and Proteomics & Bioinformatics, Case Western Reserve University, Cleveland, Ohio 44106, United States.
  • 12 CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio 44106, United States.
Abstract

Treatment of multidrug-resistant Gram-negative Bacterial pathogens represents a critical clinical need. Here, we report a novel γ-lactam pyrazolidinone that targets penicillin-binding proteins (PBPs) and incorporates a siderophore moiety to facilitate uptake into the periplasm. The MIC values of γ-lactam YU253434, 1, are reported along with the finding that 1 is resistant to hydrolysis by all four classes of β-lactamases. The druglike characteristics and mouse PK data are described along with the X-ray crystal structure of 1 binding to its target PBP3.

Figures
Products